Joint Providership Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists and the Association of Clinical Scientists. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The College of American Pathologists designates this live educational activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Learning Objectives
As a result of participating in this activity, participants will be able to:
1. Describe the role of molecular phenotyping as it applies to the diagnosis of brain tumors.
2. Describe the emerging molecular landscape of brain pathophysiology as it relates to neurogenerative disease.
3. Identify opportunities to enhance clinical laboratory quality using emerging digital strategies.
Disclaimer
The content of this accredited CE (CME) activity does not necessarily reflect the view or policies of the College of American Pathologists.
Faculty and Planning Committee Disclosure
All faculty and Planning Committee members for this activity have been required to disclose all relationships with any proprietary entity producing health care goods or services, with the exemption of non-profit or government organizations and non-health care related companies.
ACCENT® Accreditation Statement
Application has been made for ACCENT® CE credit. Information on how to obtain this credit will be provided at the meeting.